Therapy Individualization for Atopic Dermatitis

The expert panel discusses the heterogeneity of atopic dermatitis manifestation and therapy decisions for individual patients.

Related Videos
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
Berdazimer Gel Provides Complete Molluscum Clearance in 30% of Patients in 12 Weeks
Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
© 2023 MJH Life Sciences

All rights reserved.